It has become clear that diversity in all forms — ethnic, racial, gender, age — leads organizations to greater success. We know that different perspectives and experiences create more opportunities. Join us to hear what our industry is doing to invest in diversity, a powerful resource.

Moderator:

• Paul J. Hastings, President and CEO, Nkarta Therapeutics, Inc. (NASDAQ GS: NKTX)

Panelists:

• Michelle Keefe, President, Commercial Solutions, Syneos Health 
• Julia Levy, Founder and Former CEO, QLT Inc. 
• Anthony Sun, CEO, Zentalis Pharmaceuticals (NASDAQ: ZNTL) 
• Meg Zweig, COO, Rock Health

From De-risking to Value Creation – The Evolving Role of Patient Communities in Rare Disease Drug Development and Commercialization.

As patient communities and advocacy leaders become more deeply embedded in drug development, especially in rare diseases, it is imperative that organizations understand how patient engagement drives value beyond de-risking. Join Global Genes to hear insights on how patients are changing the landscape for the development of novel therapeutics and how researchers, drug developers and funders can better leverage patient-centric approaches to optimize value throughout development. Delve into how patient advocacy engagement and in drug development can act as a driver of investor value and learn how patient advocates are becoming market makers through their work in catalyzing scientific breakthroughs, data collection and sharing, reshaping clinical research, promoting access and building patient networks.

Money poured into the digital health sector in 2020 as COVID-19 pushed digital health technologies to the forefront of care. This panel will reflect on this past year's funding trends and discuss where investors are placing their bets in the future. 

Moderator:

• Logan Plaster, Editor-in-Chief, StartUp Health

Panelists:

• Katya Hancock, Investment Network Director, StartUp Health 
• Alyssa Jaffee, Partner, 7WireVentures 
• Laura Veroneau, Partner, Optum Ventures

Thursday, January 14, 
2:00–2:45pm PST 

As the most important week of the biotech calendar draws to a close, join us to hear what trends and issues this panel of journalists think will reverberate in 2021.

Biotech Showcase™ Digital will take place January 11–15. This virtual session is part of the conference program and is available to access through this sign-up page. By completing this form, you will receive an e-mail with a link to the virtual session when it is available.